Enzolytics Inc (ENZC)

[OTCShotCaller]

As an M.D. Clinical Trials Professional of 30 years, I can tell you that by bringing Dr. Moss on board, this is substantially positive news and it serves to strengthen this Company's objectives toward achieving their intended goals. They couldn't have brought a more qualified medical profession on board with clinical trials/regulatory agency experience, ties to Big Pharma, NIH, and also has expertise in drug development and Immunology. This is MAJOR GOOD NEWS!!...A Home Run Hit for this Company!

But so is the funding beginning to come into place:

The Company has also procured a commitment for funding of $500,000.00 and has received the first tranche of $250,000. These funds are earmarked for implementation of the planned combined operations and the initial steps of the merged business strategy of creating successful therapeutics against infectious diseases thereby increasing the value of the Company's extensive technology.

The second Tranche of funding will be received upon completion of the business combination documents. As part of the initial $500,000.00 funding, the Company and certain of its current convertible debt holders have agree to a 30-day standstill on issuance of any additional shares from conversions of debt.

Enzolytics has begun the process of bringing its filings current having filed the September 30, 2018, December 31, 2018 and March 31, 2019 reports.

ALL GREAT NEWS ACROSS THE BOARD!!!